MLECW
Moolec Science S.A.
NASDAQ · Healthcare · Biotechnology · LU
$0.02
−1.89%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.8M | 333.6M | 5.6M | 905.0K | — |
| Cost of Revenue | 8.5M | 219.6M | 5.2M | 1.0M | — |
| Gross Profit | (639.5K) | 114.0M | 472.6K | (143.3K) | — |
| Operating Expenses | |||||
| R&D Expense | 1.6M | 9.2M | 1.8M | 1.3M | 985.2K |
| SG&A Expense | 6.3M | 115.2M | 7.2M | 47.7M | 2.6M |
| General & Admin Expense | 5.6M | 99.3M | 6.5M | 47.4M | 2.5M |
| Selling & Marketing Expense | 742.4K | 15.9M | 643.1K | 256.4K | 105.1K |
| Other Expenses | 562.1K | — | 564.2K | (42.5M) | 39.0K |
| Total Operating Expenses | 8.5M | 124.5M | 9.5M | 6.5M | 3.7M |
| Cost and Expenses | 17.0M | 344.1M | 14.7M | 7.6M | 3.7M |
| Operating Income (EBIT) | (9.1M) | (10.5M) | (9.0M) | (6.7M) | (1.7M) |
| Non-Operating | |||||
| Interest Income | 1.7M | 944.2K | 1.9M | 693.0K | 13.3K |
| Interest Expense | 2.2M | 41.8M | 1.2M | 160.0K | 2.1K |
| Net Interest Income | (495.1K) | (40.9M) | 773.4K | 533.0K | 11.2K |
| Other Non-Op Income/Expense | 519.5K | (159.5M) | 703.5K | (45.4M) | 1.6M |
| Non-Operating Income (excl Interest) | (3.3M) | 80.8M | (1.8M) | 45.2M | — |
| EBT (Pre-Tax Income) | (8.6M) | (170.0M) | (8.3M) | (52.0M) | (93.8K) |
| Income Tax Expense | (342.8K) | 6.6M | (1.0M) | (234.5K) | — |
| Bottom Line | |||||
| Net Income | (8.3M) | (111.5M) | (7.3M) | (51.8M) | (4.5M) |
| Earnings from Cont. Ops | (8.3M) | (176.6M) | (7.3M) | (51.8M) | (93.8K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (8.3M) | (111.5M) | (7.3M) | (51.8M) | (4.5M) |
| Per Share | |||||
| Basic EPS | ($3.30) | ($258.75) | ($2.85) | ($22.50) | ($1.80) |
| Diluted EPS | ($3.30) | ($258.75) | ($2.85) | ($22.50) | ($1.80) |
| Revenue Per Share | $3.02 | $774.28 | $2.19 | $0.39 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 2.6M | 430864 | 2.6M | 2.3M | 2.5M |
| Diluted Shares Outstanding | 2.6M | 430864 | 2.6M | 2.3M | 2.5M |
| Profitability Metrics | |||||
| EBITDA | (5.2M) | (69.0M) | (6.2M) | (51.7M) | (3.7M) |
| D&A | 1.2M | 22.3M | 1.0M | 122.0K | 1.7K |
| EBIT | (6.4M) | (91.3M) | (7.2M) | (51.9M) | (3.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2025